Guiding treatment forward: how guided self-help interventions are reshaping behavioral health

The recent randomized clinical trial (RCT) by Boutelle and colleagues (1) is an important study not only in the clinical findings but equally important in its design and transformative implications. The study found that the guided self-help version of family-based behavioral treatment (gshFBT) for pediatric overweight and obesity was non-inferior to the standard version of the intervention in terms of child weight loss at post-treatment and over a 12-month follow-up. However, the guided self-help (GSH) treatment costs significantly less per family treated (approximately $1,200 savings/family), due to reduced clinician time and overhead charges. Developing and empirically testing more cost-effective behavioral treatments will ultimately save money at the individual and societal levels due to increasing access to improved physical and mental health resources. Notably, the design of the GSH intervention allows for ease of future implementation and large-scale roll out. Given the comparable clinical outcomes in the randomized trial, this study positions GSH to be the new benchmark for pediatric obesity treatment delivery.

This clinical trial represents a significant paradigm shift in how pediatric behavioral obesity treatment is provided, with the potential to increase access to care, lower treatment costs, and reduce barriers to interventions with long-lasting health and well-being outcomes. Each of these themes will be explored in detail below. With the rates of overweight and obesity among children and adolescents in the United States continuing to rise, and the associated medical and psychosocial impacts of excess weight impacting more and more youth, it is essential to design evidence-based treatments to be implementable at scale from the very beginning. GSH behavioral health treatments are well-positioned to do just that.

Increasing access and lowering costs

Estimates suggest a sobering 17–20-year delay from research to implementation of evidence-based treatments into practice (2,3). Once through this lengthy pipeline, only a subset (estimated 20–50%) of those evidence-based practices integrate into standard clinical practice (2-5). Intensive treatment options to promote behavioral change are expensive and often impractical to implement in a large-scale, systematic fashion. For one, payors and consumers want to save on cost and time, and providing options such as GSH treatments will increase accessibility and affordability of care. Additionally, patients and families may not be able to commit fully to attending highly intensive treatments and therefore may not benefit as much without receiving the proper dose of care. The authors highlighted previous research suggesting less than 30% of families who are offered family-based behavioral treatment enroll (6), which speaks to the concerns families have regarding time and resource commitment. Families of young children must balance caretaking for the target child as well as siblings and other family members, which could significantly impact their bandwidth to attend intensive treatment programs. Standard family-based behavioral treatment includes weekly group sessions with individualized behavior coaching for 6 months which totals to 23 hours (1), not including time spent commuting to and from treatment centers. For families with limited resources, weekly commutes and associated parking fees over an extended period of time can quickly become cost-prohibitive. This also comes with an opportunity cost, such that time spent attending treatment sessions means less time for family connection, sports or afterschool activities, and homework completion for these middle-aged children.

There are practical scheduling challenges as well when running in-person group-based treatments, including aligning availability among patients, families, and clinicians as well as availability and cost of treatment space. In the Boutelle et al.’s 2025 study alone, 109 of the 1,610 interested families did not proceed with randomization (and subsequently treatment) due to scheduling conflicts and another 1,145 were lost to follow-up for unknown reasons (1). Furthermore, parents and guardians may have difficulty taking time away from work responsibilities to attend intensive programs alongside their child. This could result in lost wages, which may not be feasible for all families, particularly those with limited financial resources. As obesity disproportionally affects children and adolescents from lower socioeconomic status families (7,8), which may be driven in part by psychosocial stress (9), offering traditional time-intensive behavioral treatments could unintentionally discriminate and exclude a significant proportion of families that need help. Thus, traditional in-person care models may limit access for a greater number of children who could benefit from evidence-based behavioral weight management.

Reducing barriers to evidence-based treatments

With GSH interventions, the clinical expertise and training required to effectively deliver the intervention is greatly reduced compared to standard behavioral and psychotherapy treatments. GSH treatments also have the potential to minimize therapeutic drift, as the intervention materials are standardized therefore leaving less opportunity for core therapeutic elements to be missed. Further, the use of GSH interventions often allows for non-specialist clinicians to provide care, which increases the availability of providers and reduces costs. Also, GSH has the potential to reduce clinician burnout by lightening the workload, which is a key determinant for burnout in among behavioral and mental health professionals (10-12). Based on the time calculations provided in the Boutelle et al.’s 2025 study, between 4–5 child/parent dyads could be treated in GSH for every 1 child/parent treated with traditional family-based behavioral treatment (FBT) (1). Shorten treatment sessions (20 vs. 60 minutes) may also help protect against clinical burnout and allow for greater flexibility with scheduling, which could in turn impact work satisfaction. This could potentially also improve the quality of care and thus enhance clinical outcomes, though future research exploring these downstream effects of GSH is needed.

The adaptation of telehealth into routine clinical care spurred by the coronavirus disease 2019 (COVID-19) pandemic provided increased access to evidence-based practices seemingly overnight. Previously treatments only available in specialty medical centers now could be accessed within a much greater catchment area. While patient or clinician preference may influence decisions to receive care in person or virtually, remote administration of mental and behavioral health treatments are generally supported by the outcomes data. In adolescent eating disorders, for example, retrospective analyses suggest comparable weight restoration and hospitalization prevention for family-based treatment whether provided in person or through telehealth (13). In the Boutelle et al.’s 2025 treatment study, 2 of the 5 cohorts were treatment remotely through videoconferencing due to the impact of the COVID-19 pandemic. By offering GSH virtually, more individuals can access high quality care than ever before.

If we build it, will they come?

Parent participants in the study rated the two treatments—gshFBT and FBT—equally in terms of satisfaction and acceptability. This finding indicates that participants did not seem to be concerned about less clinical contact time in the GSH arm. This data is needed to support the potential acceptability and feasibility of integrating GSH versions of evidence-based practice into routine clinical care. If patients, families, referring providers, or treating clinicians believe that “more treatment is better”, then uptake of GSH may be slow. Although not a statistically significant difference, the study saw slightly higher attendance rates for the gshFBT sessions compared to the FBT sessions [93% vs. 80% sessions attended; (1)], which again reinforces the acceptability and ease of attending GSH treatment. As noted in the paper, previous research suggests families attend twice as many GSH sessions compared to standard family-based behavioral treatment sessions (14). Beyond pediatric obesity, GSH versions of FBT for adolescents with eating disorders have been tested with preliminary results suggesting acceptability, feasibility, and improved eating disorder symptoms (15-19); a fully-powered RCT is underway to formally test the effectiveness and efficiency of GSH compared to standard FBT (20). Delivery of GSH for adolescents with eating disorders has also been piloted in group format (21), which offers additional cost-savings and provides potential added benefits of support from other group members. However, as with any group treatment, there can be unintended consequences in delivering care in a group format. For example, certain group members might disrupt learning for others, suggest incorrect or potentially harmful medical or psychiatric advice, and impact group dynamics if not carefully managed by skilled facilitators. GSH groups may experience less of these impacts, given that these treatments are often shorter with a highly structured curriculum. Research is still underway in understanding how these critical process-oriented variables in GSH group-based interventions might impact clinical care and treatment outcomes.

With any new scientific finding, reproducibility of findings should be confirmed across studies with different samples to enhance generalizability. For example, the current study only included children 7–12 years old and thus it is not known whether gshFBT would be inferior to FBT in older adolescents or in clinical samples with neurodivergence or psychiatric comorbidity. Moreover, noninferiority is not the same as efficacy, which can be tested in future trial designs. Yet the research community’s desire for further evaluation should not delay providers from offering GSH versions of clinical treatments now when supported by existing research.

The future is now

The authors propose future directions stemming from this research, including exploring child and parent preference for treatment format. Moderator analyses may help to clarify for whom gshFBT might work best. If potential baseline moderators were found, these indicators could guide clinical decision making and support clinics with stepped care models to be even more efficient with time and resources. To further increase accessibility and save on costs, future research might consider dropping the guide in GSH by testing purely self-help versions of FBT. Feasibility and acceptability of this approach warrant further investigation, as parents may or may not feel equipped to support changes in eating behaviors and physical activity without expert clinical support.

In sum, guided self-help is non-inferior, noteworthy, and necessary. Efforts should now turn to the challenges of implementation and dissemination, which if history is any indication, could take several more decades. Perhaps evidence-based GSH interventions will find a way to sped through the pipeline, in line with their cost and time-saving attributes, and roll out in routine clinical practice in record time. Whether or not GSH treatments can be widely disseminated remains to be seen. With the future health of America’s youth in jeopardy, there really is no time to waste.

Acknowledgments

None.

Footnote

Provenance and Peer Review: This article was commissioned by the editorial office, Pediatric Medicine. The article has undergone external peer review.

Peer Review File: Available at https://pm.amegroups.com/article/view/10.21037/pm-25-113/prf

Funding: None.

Conflicts of Interest: The author has completed the ICMJE uniform disclosure form (available at https://pm.amegroups.com/article/view/10.21037/pm-25-113/coif). The author has no conflicts of interest to declare.

Ethical Statement: The author is accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.

References

1. Boutelle KN, Rhee KE, Strong DR, et al. Guided Self-Help vs Group Treatment for Children With Obesity: A Randomized Clinical Trial. Pediatrics 2025;155:e2024066561. [Crossref] [PubMed]
2. Morris ZS, Wooding S, Grant J. The answer is 17 years, what is the question: understanding time lags in translational research. J R Soc Med 2011;104:510-20. [Crossref] [PubMed]
3. Rubin R. It Takes an Average of 17 Years for Evidence to Change Practice-the Burgeoning Field of Implementation Science Seeks to Speed Things Up. JAMA 2023;329:1333-6. [Crossref] [PubMed]
4. Balas EA, Boren SA. Managing Clinical Knowledge for Health Care Improvement. Yearb Med Inform 2000;65-70.
5. Bauer MS, Kirchner J. Implementation science: What is it and why should I care? Psychiatry Res 2020;283:112376. [Crossref] [PubMed]
6. Riggs KR, Lozano P, Mohelnitzky A, et al. An adaptation of family-based behavioral pediatric obesity treatment for a primary care setting: group health family wellness program pilot. Perm J 2014;18:4-10. [Crossref] [PubMed]
7. Autret K, Bekelman TA. Socioeconomic Status and Obesity. J Endocr Soc 2024;8:bvae176. [Crossref] [PubMed]
8. Goto R, Nianogo R, Okubo Y, et al. Evaluation of Obesity Trends Among US Adolescents by Socioeconomic Status, 1999-2018. JAMA Pediatr 2022;176:937-40. [Crossref] [PubMed]
9. Anekwe CV, Jarrell AR, Townsend MJ, et al. Socioeconomics of Obesity. Curr Obes Rep 2020;9:272-9. [Crossref] [PubMed]
10. Linzer M, Jin JO, Shah P, et al. Trends in Clinician Burnout With Associated Mitigating and Aggravating Factors During the COVID-19 Pandemic. JAMA Health Forum 2022;3:e224163. [Crossref] [PubMed]
11. Nassar AK, Waheed A, Tuma F. Academic Clinicians' Workload Challenges and Burnout Analysis. Cureus 2019;11:e6108. [Crossref] [PubMed]
12. O'Connor M, Morgan KE, Bailey-Straebler S, et al. Increasing the Availability of Psychological Treatments: A Multinational Study of a Scalable Method for Training Therapists. J Med Internet Res 2018;20:e10386. [Crossref] [PubMed]
13. Drury CR, Singh S, Manzano M, et al. Comparing Outcomes for Telehealth Versus In-Person Family-Based Treatment: A Retrospective Chart Review. Int J Eat Disord 2025;58:2090-104. [Crossref] [PubMed]
14. Rhee KE, Herrera L, Strong D, et al. Guided Self-Help for Pediatric Obesity in Primary Care: A Randomized Clinical Trial. Pediatrics 2022;150:e2021055366. [Crossref] [PubMed]
15. Couturier J, Sami S, Nicula M, et al. Examining the feasibility of a parental self-help intervention for families awaiting pediatric eating disorder services. Int J Eat Disord 2023;56:276-81. [Crossref] [PubMed]
16. Lock J, Darcy A, Fitzpatrick KK, et al. Parental guided self-help family based treatment for adolescents with anorexia nervosa: A feasibility study. Int J Eat Disord 2017;50:1104-8. [Crossref] [PubMed]
17. Lock J, Couturier J, Matheson BE, et al. Feasibility of conducting a randomized controlled trial comparing family-based treatment via videoconferencing and online guided self-help family-based treatment for adolescent anorexia nervosa. Int J Eat Disord 2021;54:1998-2008. [Crossref] [PubMed]
18. Matheson BE, Datta N, Welch H, et al. Parent and clinician perspectives on virtual guided self-help family-based treatment (GSH-FBT) for adolescents with anorexia nervosa. Eat Weight Disord 2022;27:2583-93. [Crossref] [PubMed]
19. Wade T, Byrne S, Fursland A, et al. Is guided self-help family-based treatment for parents of adolescents with anorexia nervosa on treatment waitlists feasible? A pilot trial. Int J Eat Disord 2022;55:832-7. [Crossref] [PubMed]
20. Gurcan H, Couturier J, Matheson B, et al. Protocol for a randomized clinical trial to confirm the effectiveness of online guided self-help family-based treatment for adolescent anorexia nervosa. Contemp Clin Trials 2024;144:107618. [Crossref] [PubMed]
21. Matheson BE, Van Wye E, Whyte A, et al. Feasibility and acceptability of a pilot studying investigating multi-family parent-only guided self-help family-based treatment for adolescent anorexia nervosa. Int J Eat Disord 2024;57:1769-75. [Crossref] [PubMed]